Cyclopentolate Other names: Cyclopentolate hydrochloride

Chemical formula: C₁₇H₂₅NO₃  Molecular mass: 291.385 g/mol  PubChem compound: 2905

Therapeutic indications

Cyclopentolate is indicated for:

Diagnostic purposes for fundoscopy and cycloplegic refraction

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Ophthalmoscopy
Cycloplegic refraction

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Uveitis

Population group: only adults (18 years old or older)

Uveitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cyclopentolate is contraindicated in the following cases:

Narrow angle glaucoma, tendency towards glaucoma

at least one of
Angle-closure glaucoma
Shallow anterior chamber of eye

Effects on ability to drive and use machines

Effects on ability to drive and use machines

Paralytic ileus

Paralytic ileus

Children with organic brain syndromes

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old)

at least one of
Delirium
Neurodevelopmental disorder
Congenital malformation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: MYDRILATE 1.0% Eye drops
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈